ID   XP207SF LCL
AC   CVCL_ZU55
SY   Xeroderma Pigmentosum 207 San Fransisco LCL
DR   Wikidata; Q98135506
RX   PubMed=16990803;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Asp121Alafs*26 (c.362delA) (A362del-1); Zygosity=Heterozygous (PubMed=16990803).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu149Lysfs*18 (c.441_442GA[2]) (c.444_445delAG) (c.445_446delGA) (GA444,445 del-2); ClinVar=VCV000557065; Zygosity=Heterozygous (PubMed=16990803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU54 ! XP207SF
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
RX   PubMed=16990803; DOI=10.1038/sj.jid.5700555; PMCID=PMC3031115;
RA   Cleaver J.E., Feeney L., Tang J.Y., Tuttle P.;
RT   "Xeroderma pigmentosum group C in an isolated region of Guatemala.";
RL   J. Invest. Dermatol. 127:493-496(2007).
//